Provision of antiretroviral therapy in resource-limited settings – a review up to August 2003

  • WHO World Health Organisation (WHO) and Department for International Development, UK


Improved prospects for expanded access to antiretroviral therapy (ART) in resource-poor settings are the result of reduced costs of antiretroviral drugs (ARVs), increased availability of cheaper generics and access to funds such as the Global Fund to Fight Acquired Immunodeficiency Syndrome (AIDS), Tuberculosis and Malaria (GFATM), private foundations, non-government organisations (NGOs), corporate initiatives, government budgets and other multilateral and bilateral donors, with the prospect of additional funding from the United States Millennium Challenge Account.
Increased affordability together with the political will has seen a rapid increase in the number of countries introducing or scaling up ART programmes. The paper aims to elucidate the requirements for ART programmes in resource-poor settings by using existing pilot experience and lessons learnt with particular regard to:
■ The feasibility of ART in resource-poor settings.
■ The different approaches being taken to delivery of ART.
■ The issues to be considered in scaling up ART provision.
Southern African Journal of HIV Medicine Vol. 5(1) 2004: 34-39

Journal Identifiers

eISSN: 2078-6751
print ISSN: 1608-9693